BMOD:SCIENTIFIC ADVISORY BOARD
Marty Jacobson, PhD, is an Adjunct Professor of microbiology at Mesa State College in Colorado and a scientist at the Saccomanno Institute, St. Mary’s Hospital in Grand Junction, Colorado. He has published dozens of scientific papers.
Srinivas Mukkamala, PhD, is an Adjunct Professor at the New Mexico Institute for Mining and Technology. His research focus is on information assurance, digital forensics, knowledge mining, applied soft computing techniques, bioinformatics, information and network security practices.
David Faguy, PhD, is an Adjunct Assistant Professor, Department of Molecular Genetics and Microbiology, at the University of New Mexico School of Medicine. He has published numerous peer-reviewed research publications.
MEDICAL ADVISORY BOARD
Thomas Bauer, MD, is Chief of Thoracic Surgery at Helen F Graham Cancer Center in Newark, Delaware, and Principal Investigator of the Biomoda Phase II clinical trial currently underway. Dr. Bauer is Principal Investigator of three additional lung cancer screening trials through I-ELCAP and one breath test screen. He has two other current academic appointments (Jefferson Medical College and Arcadia University). Dr. Bauer has authored dozens of peer- and nonpeer-reviewed publications and abstracts. He serves on many committees and programs and belongs to dozens of associations.
Dan Merrick, MD, is known for his work in anatomic and clinical pathology, and molecular genetic pathology. He has published several papers on lung cancer and is an expert on sputum cytology. Dr. Merrick graduated from the University of Washington Medical School.
Tim Kennedy, MD, is associated with the University of Colorado and specializes in internal medicine, pulmonology and cytopathology. He is an expert in sputum cytology. Dr. Kennedy has authored many peer-reviewed publications, belongs to dozens of professional societies and serves on many committees. He has held faculty positions at the University of Arizona and University of Colorado Health Sciences Center.
Ramesh Gopal, MD, is a board-certified radiation oncologist serving as Medical Director of radiation treatment at the M.D. Anderson Cancer Center satellite at the Presbyterian Kaseman Hospital in Albuquerque, New Mexico.
Lara Patriquin, MD, is a Principal Investigator for Biomoda’s Phase II clinical trial. Dr. Patriquin is a radiologist at Radiology Associates and Presbyterian Hospital.
Steve Groshong, MD, PhD, is a pathologist at the National Jewish Hospital in Denver and Assistant Professor at the University of Colorado, Denver.
BMOD: CLINICAL ADVISORY BOARD
Richard Phillips, MSPH, PhD, is a Principal Consultant in medical device development at Quintiles Consulting. Previously, he worked in the FDA’s Office of Device Evaluation, serving as a first-line scientific reviewer in the Chemistry and Toxicology Branch, Division of Clinical Laboratory Devices, and then as Chief, Anesthesiology and Defibrillator Devices Branch, Division of Cardiovascular, Respiratory and Neurological Devices. Before joining FDA,
Dr. Phillips worked for three in-vitro diagnostic device companies as Director of Clinical Research/Clinical Affairs. Dr. Phillips is a Diplomate of the American Board of Forensic Toxicology and the author of numerous papers in clinical chemistry, analytical and forensic toxicology, and in-vitro diagnostic devices. He is a member of the American Association for Clinical Chemistry, Association of Clinical Scientists, Clinical Ligand Assay Society, Society of Forensic Toxicologists, and the American Academy of Forensic Sciences. Dr. Phillips earned his BS in biology and chemistry from Marian University, his MSPH from the University of North Carolina, Chapel Hill, and his PhD from Indiana University.
Richard Holcomb, PhD, is an Associate Senior Consultant with Quintiles. Dr. Holcomb works with clients in the medical device, pharmaceutical, biologic and biotechnology industries to develop and implement preclinical and clinical development plans, with special emphasis on medical devices regulated by the FDA. Dr. Holcomb has a B.S. in mathematics from Michigan Technological University, an MS and a PhD in biometry from the University of Minnesota.
Tom Zimmerman, Contract Research Organization (CRO) Project Advisor with Alquest, Inc., has 25 years experience in clinical laboratory operations and management. He is an expert in laboratory logistics, data management, point-of-care issues, quality assurance and validation. Mr. Zimmerman has worked for Nichols Institute Reference Laboratories, SmithKline Beecham Clinical Laboratories, Focus Diagnostics, Medtox Laboratories, ViroMed Laboratories, and Mayo Medical Laboratories/Clinical Trial Services where he was senior analyst programmer and operations administrator for Core Laboratory Services. Tom earned his BA from St. Cloud State University in Minnesota.
AI
